EXR-KJENS1sPlvS2-AN (Collection)

Persistent Id:dbgap:phs000727.v1.p1
Has Time Series Data:0
Description:Analysis Entry
Creation Time:2014-10-24 00:00:00.000000
Abbreviation:KJENS1sPlvS2
Results found

Linked to

 

Label

Description

 

Biofluid

The portion of blood plasma that excludes clotting factors.

Project

We profiled the miRNA contents from cerebrospinal fluid and serum (using next generation sequencing)...

Biofluid

A clear, colorless, bodily fluid, that occupies the subarachnoid space and the ventricular system ar...

Subject

A subject from ExRNA produced as part of the exRNA Atlas project

Subject

A subject from ExRNA produced as part of the exRNA Atlas project

Subject

A subject from ExRNA produced as part of the exRNA Atlas project

Subject

A subject produced as part of the exRNA Atlas project

Subject

A subject from ExRNA produced as part of the exRNA Atlas project

Biosample

A biosample from ExRNA produced as part of the EXR KJENS1ADPD0000 ST project

Subject

A subject from ExRNA produced as part of the exRNA Atlas project

  • Biofluid

    The portion of blood plasma that excludes clotting factors.


  • Project

    We profiled the miRNA contents from cerebrospinal fluid and serum (using next generation sequencing)...


  • Biofluid

    A clear, colorless, bodily fluid, that occupies the subarachnoid space and the ventricular system ar...


  • Subject

    A subject from ExRNA produced as part of the exRNA Atlas project


  • Subject

    A subject from ExRNA produced as part of the exRNA Atlas project


  • Subject

    A subject from ExRNA produced as part of the exRNA Atlas project


  • Subject

    A subject produced as part of the exRNA Atlas project


  • Subject

    A subject from ExRNA produced as part of the exRNA Atlas project


  • Biosample

    A biosample from ExRNA produced as part of the EXR KJENS1ADPD0000 ST project


  • Subject

    A subject from ExRNA produced as part of the exRNA Atlas project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.